trending Market Intelligence /marketintelligence/en/news-insights/trending/xDGPvNKD8H0N41-RzJUTxQ2 content esgSubNav
In This List

Tonix Pharmaceuticals regains Nasdaq compliance

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Tonix Pharmaceuticals regains Nasdaq compliance

Tonix Pharmaceuticals Holding Corp. regained compliance with Nasdaq's $1 minimum bid price requirement for continued listing on the stock exchange.

The company regained compliance thanks to a 1-for-10 reverse stock split to increase the per share trading price of its shares.